bibliographic resource 4817808 [br/4817808]
https://w3id.org/oc/corpus/br/4817808

is a

• document
• article

title

• Updated results from a phase I study of nivolumab (Nivo) in combination with ipilimumab (Ipi) in metastatic renal cell carcinoma (mRCC): The CheckMate 016 study

publication date

• 2016-01-01

contributor

• https://w3id.org/oc/corpus/ar/18618600
• https://w3id.org/oc/corpus/ar/18618601
• https://w3id.org/oc/corpus/ar/18618602
• https://w3id.org/oc/corpus/ar/18618603
• https://w3id.org/oc/corpus/ar/18618604
• https://w3id.org/oc/corpus/ar/18618605
• https://w3id.org/oc/corpus/ar/18618606
• https://w3id.org/oc/corpus/ar/18618607
• https://w3id.org/oc/corpus/ar/18618608
• https://w3id.org/oc/corpus/ar/18618609
• https://w3id.org/oc/corpus/ar/18618610
• https://w3id.org/oc/corpus/ar/18618611
• https://w3id.org/oc/corpus/ar/18618612
• https://w3id.org/oc/corpus/ar/18618613
• https://w3id.org/oc/corpus/ar/18618614
• https://w3id.org/oc/corpus/ar/18618615
• https://w3id.org/oc/corpus/ar/18618616

identifier

• https://w3id.org/oc/corpus/id/12139554
• https://w3id.org/oc/corpus/id/12139555
• https://w3id.org/oc/corpus/id/9740480
• https://w3id.org/oc/corpus/id/9740481

part of

• https://w3id.org/oc/corpus/br/4070241